Moderna
MRNA
#1187
Rank
A$24.32 B
Marketcap
$63.21
Share price
7.48%
Change (1 day)
-47.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$24.32 Billion

As of November 2024 Moderna has a market cap of A$24.32 Billion. This makes Moderna the world's 1187th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024A$24.32 B-56.29%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Nov 22nd, 2024 the market cap of Moderna was reported to be:

A$24.32 Billion
by Yahoo Finance info icon info icon
A$24.32 Billion
by CompaniesMarketCap info icon info icon
A$24.32 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.14 B-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$385.76 B 1,485.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.28 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$48.56 B 99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$320.56 B 1,217.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.54 B-85.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$574.43 B 2,261.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.57 B-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA